Regular paper
Effects of nitric oxide-containing compounds on increases in cytosolic ionized Ca2+ and on aggregation of human platelets

https://doi.org/10.1016/0922-4106(93)90057-GGet rights and content

Abstract

The present study was undertaken to determine the modulatory effects of nitric oxide (NO)-releasing compounds on increases in cytosolic ionized calcium ([Ca2+]i) and on aggregation of gel-filtered human platelets induced via diverse agonists. We used various sydnonimines and organic nitrates as donors of NO. Gel-filtered and fura-2-loaded platelets were stimulated with ADP (4–8 μM), collagen (2–10 μg/ml) or thrombin (0.02–0.05 IU/ml), respectively. Half-maximal inhibiting effects of sydnonimines on agonist-evoked increases in [Ca2+]i were observed between 30 and 1000 nM, while is the bioactive metabolite of compounds on aggregation were between 3 and 500 nM. The compound C 87–3754, which is the bioactive metabolite of pirsidomine, was a much stronger inhibitor of increases in [Ca2+]i than of platelet aggregation. This was due to an enhanced NO release from this compound exposed to ultraviolet light during Ca2+ measurement. The organic nitrates isosorbide 5-mononitrate and nicorandil inhibited both aggregation and increase of cytosolic ionized calcium in stimulated platelets at half-maximal concentrations of approximately 200 μM. The present results suggest that some of the effects of NO on platelets are independent of cytosolic ionized calcium. The results also suggest that some of the inhibitory effects of NO-releasing compounds correspond rather to the presence of the A forms (NO-containing intermediates) than to the presence of free NO.

References (35)

  • M.F. Simon et al.

    Effects of a stimulant of guanylate cyclase, SIN 1, on calcium movements and phospholipase C activation in thrombin-stimulated human platelets

    Biochem. Pharmacol.

    (1988)
  • S. Timmons et al.

    Separation of human platelets from plasma proteins including factor VIIIvwf by a combined albumin gradient-gel filtration method using HEPES buffer

    Thromb. Res.

    (1978)
  • A.F. Vanin

    Endothelium-derived relaxing factor is a nitrosyl iron complex with thiol ligands

    FEBS Lett.

    (1991)
  • Y. Asahi et al.

    Chemical and kinetic study on stabilities of 3-morpholino-sydnonimine and its N-ethoxycarbonyl derivate

    Chem. Pharm. Bull.

    (1971)
  • E. Böhme et al.

    Effects of sodium nitroprusside and other smooth muscle relaxants on cyclic GMP formation in smooth muscle and platelets

    Adv. Cyclic Nucleotide Res.

    (1978)
  • E. Böhme et al.

    Regulation of cyclic GMP formation by soluble guanylate cyclase: stimulation by NO-containing compounds

    Adv. Cyclic Nucleotide Protein Phosphorylation Res.

    (1984)
  • H. Bohn et al.

    Oxygen and oxydation promote the release of nitric oxide from sydnonimines

    J. Cardiovasc. Pharmacol.

    (1989)
  • Cited by (55)

    • Inhaled nitric oxide improves post-cardiac arrest outcomes via guanylate cyclase-1 in bone marrow-derived cells

      2022, Nitric Oxide - Biology and Chemistry
      Citation Excerpt :

      We observed that CA/CPR increased platelet P-selectin expression, TXA2 secretion, and hypercoagulability, suggesting platelet activation in post-CA mice. NO/GC/cGMP signaling inhibits platelet aggregation [18,32–36], secretion [70], adhesion [71], and binding of fibrinogen to its integrin receptor, GpIIb/IIIa, on the platelet membrane [72–74]. Along these lines, we observed that iNO inhibited the platelet activation and secretion of TXA2 and attenuated hypercoagulability and cerebral microvascular occlusion after CA/CPR.

    • Protein kinase A mediates inhibition of the thrombin-induced platelet shape change by nitric oxide

      2004, Blood
      Citation Excerpt :

      Regulation of platelet activation is an important physiologic function of the vascular endothelium including release of nitric oxide (NO),13 a potent inhibitor of platelet aggregation, secretion, adhesion, and binding of fibrinogen to integrin glycoprotein IIbIIIa (GpIIbIIIa).14-17 Conflicting results have, however, been reported about the effect of NO on shape change.18-21 The inhibitory effects of NO on platelet activation have been considered to be due to activation of the soluble guanylyl cyclase causing production of cyclic guanosine monophosphate (cGMP) and subsequent activation of cGMP-dependent protein kinase G (PKG).22

    • Differential expression of functional guanylyl cyclases in melanocytes: Absence of nitric-oxide-sensitive isoform in metastatic cells

      2001, Journal of Investigative Dermatology
      Citation Excerpt :

      For testing the activation of sGC, melanocytes were treated for 5 min with SIN-1 (0.01–1 mM) (Feelisch et al. 1989;Ivanova et al. 1993). Denitrosylated solutions of SIN-1 (which contain the inactive byproducts) as controls were obtained as described elsewhere (Ivanova et al. 1997). For activation of GC-A, GC-B, and GC-C the melanocytes were incubated for 15 min with human α-ANP1-28, BNP32, CNP22, guanylin (Peninsula Lab., St. Helens, U.K.), and STa toxin (Sigma, St. Louis, MO) in the range of 0.001–1 μM.

    View all citing articles on Scopus

    Preliminary results of this study have been reported at the ‘Wintertagung der Deutschen Gessellschaft für Pharmakologie’ (Ivanova et al., 1991).

    View full text